Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Prevalence of hypertension and pre-hypertension in the Middle East region: a systematic review & meta-analysis

Abstract

Hypertension is a leading cause of mortality and morbidity globally. This study aimed to obtain an overall regional estimate of the prevalence of hypertension and pre-hypertension and present the disease pattern based on the age and time in the Middle East region. We searched PubMed, Google Scholar, Medline for articles on the prevalence of hypertension, pre-hypertension among countries of the Middle East region from 1999 to 2019. STATA-14 was used to analyze the data. Data were pooled using a random-effects meta-analysis model, and heterogeneity between studies was assessed using I2 test and subgroup analysis. A total of eighty-three studies with 479816 participants met the criteria for inclusion in the meta-analysis process. The overall prevalence of hypertension and pre-hypertension in the Middle East region were 24.36% (95% CI: 19.06–31.14) and 28. 60% (95% CI: 24.19–33.80), respectively. An increasing trend in the prevalence of hypertension was observed with the increasing age. The prevalence of hypertension in the ≤ 49-year-old age group was 17.13% (95% CI: 13.79–21.27) and in people over 60 years was 61.24% (95% CI: 55.30–67.81) (P < 0.001). This pattern has been similar among both males and females. On the other hand, a decreasing trend in the prevalence of pre-hypertension was observed with the increasing age. The increasing trend in the prevalence of hypertension and decreasing trend in the prevalence of pre-hypertension with age are significant concerns in the Middle East region. Screening for the prevention and control of hypertension should prioritize public health programs.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3

References

  1. Bundy JD, He J. Hypertension and related cardiovascular disease burden in China. Ann Glob Health. 2016;82:227–33.

    PubMed  Article  Google Scholar 

  2. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: a review. World J Cardiol. 2012;4:327.

    PubMed  PubMed Central  Article  Google Scholar 

  3. Perkovic V, Huxley R, Wu Y, Prabhakaran D, MacMahon S. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension. 2007;50:991–7.

    CAS  PubMed  Article  Google Scholar 

  4. Negi PC, Chauhan R, Rana V, Lal K. Epidemiological study of non-communicable diseases (NCD) risk factors in tribal district of Kinnaur, HP: Aa cross-sectional study. Indian Heart J. 2016;68:655–62.

    PubMed  PubMed Central  Article  Google Scholar 

  5. Yusufali AM, Khatib R, Islam S, Alhabib KF, Bahonar A, Swidan HM, et al. Prevalence, awareness, treatment and control of hypertension in four Middle East countries. J Hypertens. 2017;35:1457–64.

    CAS  PubMed  Article  Google Scholar 

  6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

    PubMed  Article  Google Scholar 

  7. Motlagh B, O’Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovas Prev Rehabil. 2009;16:268–80.

    Article  Google Scholar 

  8. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–27.

    PubMed  Article  Google Scholar 

  9. Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa: a systematic review. Hypertension. 2007;50:1012–8.

    CAS  PubMed  Article  Google Scholar 

  10. Katibeh M, Sanjari Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H. Hypertension and associated factors in the Islamic Republic of Iran: a population-based study. East Mediterr Health J. 2020;26:301–11.

    Article  Google Scholar 

  11. Collaboration PS. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.

    Article  Google Scholar 

  12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–52.

    CAS  PubMed  Article  Google Scholar 

  13. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.

    PubMed  PubMed Central  Article  Google Scholar 

  14. Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19:170–6.

    CAS  PubMed  Google Scholar 

  15. Han H, Guo W, Shi W, Yu Y, Zhang Y, Ye X, et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep. 2017;7:1–9.

    Article  CAS  Google Scholar 

  16. Liang Z, Xie B, Li J, Wang X, Wang S, Meng S, et al. Hypertension and risk of prostate cancer: a systematic review and meta-analysis. Sci Rep. 2016;6:1–7.

    CAS  Article  Google Scholar 

  17. Xuan K, Zhao T, Sun C, Patel AS, Liu H, Chen X, et al. The association between hypertension and colorectal cancer: a meta-analysis of observational studies. Eur J Cancer Prev. 2021;30:84–96.

    CAS  PubMed  Article  Google Scholar 

  18. Hidayat K, Du X, Zou S-Y, Shi B-M. Blood pressure and kidney cancer risk: meta-analysis of prospective studies. J Hypertens. 2017;35:1333–44.

    CAS  PubMed  Article  Google Scholar 

  19. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.

    PubMed  PubMed Central  Article  Google Scholar 

  20. Guo X, Zou L, Zhang X, Li J, Zheng L, Sun Z, et al. Prehypertension: a meta-analysis of the epidemiology, risk factors, and predictors of progression. Tex Heart Inst J. 2011;38:643.

    PubMed  PubMed Central  Google Scholar 

  21. Batal M, Steinhouse L, Delisle H. The nutrition transition and the double burden of malnutrition. Med Sante Trop. 2018;28:345–50.

    CAS  PubMed  Google Scholar 

  22. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  23. Neupane D, McLachlan CS, Sharma R, Gyawali B, Khanal V, Mishra SR, et al. Prevalence of hypertension in member countries of South Asian Association for Regional Cooperation (SAARC): systematic review and meta-analysis. Medicine. 2014;93:e74.

    PubMed  PubMed Central  Article  Google Scholar 

  24. Meiqari L, Essink D, Wright P, Scheele F. Prevalence of hypertension in Vietnam: a systematic review and meta-analysis. Asia Pac J Public Health. 2019;31:101–12.

    PubMed  PubMed Central  Article  Google Scholar 

  25. Huang Y, Guo P, Karmacharya BM, Seeruttun SR, Xu DR, Hao Y. Prevalence of hypertension and prehypertension in Nepal: a systematic review and meta-analysis. Glob Health Res Policy. 2019;4:11.

    PubMed  PubMed Central  Article  Google Scholar 

  26. Mendis S. Hypertension: a silent contributor to the global cardiovascular epidemic. Reg Health Forum; 2013;17:1–6.

  27. Naing C, Aung K. Prevalence and risk factors of hypertension in Myanmar: a systematic review and meta-analysis. Medicine. 2014;93:e100.

    PubMed  PubMed Central  Article  Google Scholar 

  28. Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran Univ Heart Cent. 2016;11:159.

    Google Scholar 

  29. Stocks T, Van Hemelrijck M, Manjer J, Bjørge T, Ulmer H, Hallmans G, et al. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension. 2012;59:802–10.

    CAS  PubMed  Article  Google Scholar 

  30. Seretis A, Cividini S, Markozannes G, Tseretopoulou X, Lopez DS, Ntzani EE, et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies. Sci Rep. 2019;9:1–12.

    CAS  Article  Google Scholar 

  31. Baade PD, Meng X, Sinclair C, Youl P. Estimating the future burden of cancers preventable by better diet and physical activity in Australia. Med J Aust. 2012;196:337–40.

    PubMed  Article  Google Scholar 

  32. Hamet P. Cancer and hypertension: an unresolved issue. Hypertension. 1996;28:321–4.

    CAS  PubMed  Article  Google Scholar 

  33. Al-Eisa IS, Al-Terkit AM, Al-Mutar MS, Azab MS, Radwan MM, Al-Eisa I. Risk factors, diseases and Socio-demographic background distribution among attendants of Health Promotion Clinic at Capital Health Region, Kuwait. Middle East J Family Med. 2005;3.

  34. Abu-Saad K, Chetrit A, Eilat-Adar S, Alpert G, Atamna A, Gillon-Keren M, et al. Blood pressure level and hypertension awareness and control differ by marital status, sex, and ethnicity: a population-based study. Am J Hypertens. 2014;27:1511–20.

    CAS  PubMed  Article  Google Scholar 

  35. Steinvil A, Leshem‐Rubinow E, Berliner S, Justo D, Finn T, Ish‐shalom M, et al. Vitamin D deficiency prevalence and cardiovascular risk in Israel. Eur J Clin Investig. 2011;41:263–8.

    Article  Google Scholar 

  36. Hayek S, Ifrah A, Enav T, Shohat T. Prevalence, correlates, and time trends of multiple chronic conditions among Israeli adults: estimates from the Israeli National Health Interview Survey, 2014–2015. Prev Chronic Dis. 2017;14:E64.

    PubMed  PubMed Central  Article  Google Scholar 

  37. Saeed AA, Al-Hamdan NA. Anthropometric risk factors and predictors of hypertension among Saudi adult population–a national survey. J Epidemiol Glob Health. 2013;3:197–204.

    PubMed  PubMed Central  Article  Google Scholar 

  38. Bogari D, Bakalka G, Hazzazi L, Jan A, Elias W, McDonald N, et al. The prevalence of hypertension in endodontic clinics: a pilot study. Dentistry. 2016;6:1–4.

    Article  Google Scholar 

  39. Aldiab A, Shubair MM, Al-Zahrani JM, Aldossari KK, Al-Ghamdi S, Househ M, et al. Prevalence of hypertension and prehypertension and its associated cardioembolic risk factors; a population based cross-sectional study in Alkharj, Saudi Arabia. BMC Public Health. 2018;18:1–9.

    Article  Google Scholar 

  40. Ibrahim NK, Hijazi NA, Al-Bar AA. Prevalence and determinants of prehypertension and hypertension among preparatory and secondary school teachers in Jeddah. J Egypt Public Health Assoc. 2008;83:183–203.

    PubMed  Google Scholar 

  41. Al-Nozha MM, Abdullah M, Arafah MR, Khalil MZ, Khan NB, Al-Mazrou YY, et al. Hypertension in saudi arabia. Saudi Med J. 2007;28:77.

    PubMed  Google Scholar 

  42. Al-Hamdan N, Saeed A, Kutbi A, Choudhry A, Nooh R. Characteristics, risk factors, and treatment practices of known adult hypertensive patients in Saudi Arabia. Int J Hypertens. 2011;2010;168739.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Al-Mohaissen MA, Al-Obaid QY, AlGhamdi WA, Al-Alyani HS, Dahman SM, Al-Wahhabi NA, et al. Prevalence and determinants of hypertension and high normal blood pressure among young adult Saudi females. Fam Community Health. 2017;40:221–30.

    PubMed  Article  Google Scholar 

  44. Altemani A. Prevalence of diabetes mellitus, hypertension and hyperlipidemia among students and employees in University of Tabuk, Saudi Arabia. Eur Sci J. 2016;12. https://doi.org/10.19044/esj.2016.v12n6p67.

  45. Elkhalifa AM, Kinsara AJ, Almadani DA. Prevalence of hypertension in a population of healthy individuals. Med Princ Pract. 2011;20:152–5.

    PubMed  Article  Google Scholar 

  46. Baig M, Gazzaz ZJ, Gari MA, Al-Attallah HG, Al-Jedaani KS, Mesawa AT, et al. Prevalence of obesity and hypertension among University students’ and their knowledge and attitude towards risk factors of Cardiovascular Disease (CVD) in Jeddah, Saudi Arabia. Pak J Med Sci. 2015;31:816.

    PubMed  PubMed Central  Google Scholar 

  47. Ahmed HG, Ginawi IA, AL-HAZIMI AM. Prevalence of hypertension in Hail region, KSA: in a comprehensive survey. Int J Sci: Basic Appl Res. 2014;17:288–96.

    Google Scholar 

  48. Bayameen M, Al-Raddadi M, Hassan A, Banamah O, Mohammed M. Prevalence of metabolic syndrome among primary health care attendees in King Fahad Armed Forces Hospital in Jeddah. Arch Med. 2018;10:9.

    Google Scholar 

  49. Gutierrez J, Alloubani A, Mari M, Alzaatreh M. Cardiovascular disease risk factors: hypertension, diabetes mellitus and obesity among Tabuk Citizens in Saudi Arabia. Open Cardiovasc Med J. 2018;12:41.

    PubMed  PubMed Central  Article  Google Scholar 

  50. Al Riyami A, Afifi M. Clustering of cardiovascular risk factors among Omani adults. East Mediterranean Health J. 2003;9:893–903.

    CAS  Article  Google Scholar 

  51. Abd El-Aty MA, Meky FA, Morsi MM, Al-Lawati JA, El Sayed MK. Hypertension in the adult Omani population: predictors for unawareness and uncontrolled hypertension. J Egypt Public Health Assoc. 2015;90:125–32.

    PubMed  Article  Google Scholar 

  52. Barakat MN, Youssef RM. Prevalence of dysglycemia and other cardiovascular risk factors among the rural population of Oman. Hypertension. 2008;129:14.7.

    Google Scholar 

  53. Al-Maqbali AA, Temple-Smith M, Ferler J, Blackberry I. Prevalence and determinants of pre-hypertension among Omani adults attending non-communicable disease screening program in primary care setting in Sohar city. Oman Med J. 2013;28:316.

    PubMed  PubMed Central  Article  Google Scholar 

  54. Hasab A, Jaffer A, Hallaj Z. Blood pressure patterns among the Omani population. East Mediterranean Health J. 1999;5:46–54. 1999

    CAS  Article  Google Scholar 

  55. Khdour M, Hallak H, Shaeen M, Jarab A, Al-Shahed Q. Prevalence, awareness, treatment and control of hypertension in the Palestinian population. J Hum Hypertens. 2013;27:623–8.

    CAS  PubMed  Article  Google Scholar 

  56. Tayem YI, Yaseen NA, Khader WT, Abu Rajab LO, Ramahi AB, Saleh MH. Prevalence and risk factors of obesity and hypertension among students at a central university in the West Bank. Libyan J Med. 2012;7:19222.

    Article  Google Scholar 

  57. Gunaid A. Prevalence of known diabetes and hypertension in the Republic of Yemen. East Mediterranean Health J. 2002;8:374–85.

    CAS  Article  Google Scholar 

  58. Modesti PA, Bamoshmoosh M, Rapi S, Massetti L, Al-Hidabi D, Al Goshae H. Epidemiology of hypertension in Yemen: effects of urbanization and geographical area. Hypertension Res. 2013;36:711–7.

    Article  Google Scholar 

  59. Baynouna LM, Revel AD, Nagelerke N, Omar A, Ahmed N. High prevalence of the cardiovascular risk factors in Al-Ain, United Arab Emirates. Saudi Med J. 2008;29:1173–8.

    PubMed  Google Scholar 

  60. Önal A, Erbil S, Özel S, Aciksari K, Tumerdem Y. The prevalence of and risk factors for hypertension in adults living in Istanbul. Blood Press. 2004;13:31–6.

    PubMed  Article  Google Scholar 

  61. Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, et al. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord. 2009;7:427–34.

    PubMed  Article  Google Scholar 

  62. Sönmez H, Başak O, Camcı C, Baltacı R, Karazeybek H, Yazgan F, et al. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydın, Turkey. J Hum Hypertens. 1999;13:399–404.

    PubMed  Article  Google Scholar 

  63. Önen C, Güneş G. Relationship between regional food and hypertension in the East of Turkey. Int J Community Med Public Health. 2019;6:2306.

    Article  Google Scholar 

  64. Ayranci U, Unsal A, Tozun M. Distribution of blood pressure and evaluation of risk factors for hypertension among women in Turkey. 2008;37:61–74.

  65. Tugay Aytekin N, Pala K, Irgil E, Akis N, Aytekin H. Distribution of blood pressures in Gemlik District, north‐west Turkey. Health Soc Care Community. 2002;10:394–401.

    PubMed  Article  Google Scholar 

  66. Doğan N, Toprak D, Demir S. Hypertension prevalence and risk factors among adult population in Afyonkarahisar region: a cross-sectional research. Anatol J Cardiol. 2012;12:47–52.

    Google Scholar 

  67. Erem C, Yildiz R, Kavgaci H, Karahan C, Deger O, Çan G, et al. Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city). Diabetes Res Clin Pract. 2001;54:203–8.

    CAS  PubMed  Article  Google Scholar 

  68. Ince N, Issever H, Ince H, Ozyildirim B, Isik E, Hapcoglu B, et al. Hypertension in leather tanning workers working in Istanbul, Turkey. Singap Med J. 2008;49:874.

    CAS  Google Scholar 

  69. Vaziri Y, Bulduk S, Shadman Z, Bulduk EO, Hedayati M, Koc H, et al. Lean body mass as a predictive value of hypertension in young adults, in Ankara, Turkey. Iran J Public Health. 2015;44:1643.

    PubMed  PubMed Central  Google Scholar 

  70. Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34:1208.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  71. Baltaci D, Erbilen E, Turker Y, Alemdar R, Aydin M, Kaya A, et al. Predictors of hypertension control in Turkey: the MELEN study. Eur Rev Med Pharmacol Sci. 2013;17:1884–8.

    CAS  PubMed  Google Scholar 

  72. Didem A, Unal A, Alaettin U, Mustafa T. Prevalence of hypertension among individuals aged 50 years and over and its impact on health related quality of life in a semi-rural area of western Turkey. Chin Med J. 2008;121:1524–31.

    Article  Google Scholar 

  73. Sarıışık A, Oğuz A, Uzunlulu M. Control of hypertension in Turkey–is it improving? The Kocaeli 2 study. Turk Kardiyol Dern Ars. 2009;37:13–6.

    PubMed  Google Scholar 

  74. Hacihasanoglu R, Inandi T, Yildirim A, KARAKURT P, Saglam R. Frequency, awareness, treatment and control of hypertension in the over 40 population of Erzincan. Turk Silahli Kuvvetleri koruyucu Hekim Bul. 2014;13:357.

    PubMed  PubMed Central  Google Scholar 

  75. Bener A, Darwish S, Al-Hamaq AO, Mohammad RM, Yousafzai MT. Association of PPARγ2 gene variant Pro12Ala polymorphism with hypertension and obesity in the aboriginal Qatari population known for being consanguineous. Appl Clin Genet. 2013;6:103.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  76. Al Ali R, Rastam S, Fouad FM, Mzayek F, Maziak W. Modifiable cardiovascular risk factors among adults in Aleppo, Syria. Int J Public Health. 2011;56:653–62.

    PubMed  Article  Google Scholar 

  77. Ramadan H, Naja F, Fouad F, Antoun E, Jaffa M, Chaaban R, et al. Prevalence and correlates of metabolic syndrome in pre-crisis Syria: call for current relief efforts. East Mediterranean Health J. 2016;22:668–75.

    CAS  Article  Google Scholar 

  78. Salameh P, Chahine M, Hallit S, Farah R, Zeidan RK, Asmar R, et al. Hypertension prevalence and living conditions related to air pollution: results of a national epidemiological study in Lebanon. Environ Sci Pollut Res. 2018;25:11716–28.

    Article  Google Scholar 

  79. Chaaya M, Phung K, Atweh S, El Asmar K, Karam G, Khoury RM, et al. Socio-demographic and cardiovascular disease risk factors associated with dementia: results of a cross-sectional study from Lebanon. Preventive Med Rep. 2018;9:1–5.

    Article  Google Scholar 

  80. Noubani A, Nasreddine L, Sibai AM, Tamim H, Isma’eel H. Prevalence, awareness, and control of hypertension in Greater Beirut Area, Lebanon. Int J Hypertens. 2018;2018:5419861.

    PubMed  PubMed Central  Article  Google Scholar 

  81. Kanj H, Khalil A, Kossaify M, Kossaify A. Predictors of undiagnosed and uncontrolled hypertension in the local community of Byblos, Lebanon. Health Serv insights. 2018;11:1178632918791576.

    PubMed  PubMed Central  Google Scholar 

  82. Cherfan M, Blacher J, Asmar R, Chahine MN, Zeidan RK, Farah R, et al. Prevalence and risk factors of hypertension: A nationwide cross‐sectional study in Lebanon. J Clin Hypertension. 2018;20:867–79.

    Article  Google Scholar 

  83. Mouhtadi BB, Kanaan RMN, Iskandarani M, Rahal MK, Halat DH. Prevalence, awareness, treatment, control and risk factors associated with hypertension in Lebanese adults: a cross sectional study. Glob Cardiol Sci Pract. 2018;2018. https://doi.org/10.21542/gcsp.2018.6

  84. Cherfan M, Vallée A, Kab S, Salameh P, Goldberg M, Zins M, et al. Unhealthy behavior and risk of hypertension: the CONSTANCES population-based cohort. J Hypertens. 2019;37:2180–9.

    CAS  PubMed  Article  Google Scholar 

  85. N Al-Asadi J, A Ali H. Prevalence and lifestyle determinants of hypertension among secondary school female teachers in Basrah. Med J Basrah Univ. 2009;27:90–4.

    Article  Google Scholar 

  86. Cetorelli V, Burnham G, Shabila N. Prevalence of non-communicable diseases and access to health care and medications among Yazidis and other minority groups displaced by ISIS into the Kurdistan Region of Iraq. Confl Health. 2017;11:1–7.

    Article  Google Scholar 

  87. Albasry Z, Najim HD, Al-Taie A. Perception of predictive confounders for the prevalence of hypertension among Iraqi population: a pilot study. Int J Pharmacol Pharm Sci. 2019;13:133–8.

    Google Scholar 

  88. Saka M, Shabu S, Shabila N. Prevalence of hypertension and associated risk factors in older adults in Kurdistan. Iraq East Mediterranean Health J. 2020;26:268–75.

    Article  Google Scholar 

  89. Panagiotakos DB, Kinlaw M, Papaerakleous N, Papoutsou S, Toutouzas P, Polychronopoulos E. Depressive symptomatology and the prevalence of cardiovascular risk factors among older men and women from Cyprus; the MEDIS (Mediterranean Islands Elderly) epidemiological study. J Clin Nurs. 2008;17:688–95.

    PubMed  Article  Google Scholar 

  90. Zachariades AG, Zachariadou T, Adamide T, Anagnostopoulou U, Georgiou A, Gourgoulianis KI. Prevalence of chronic obstructive pulmonary disease in Cyprus: a population-based study. J Chronic Obstr Pulm Dis. 2012;9:259–67.

    Article  Google Scholar 

  91. Abu-Zaiton A, Al-Fawwaz A. Prevalence of diabetes, obesity, hypertension and associated factors among students of Al-albayt University, Jordan. World J Med Sci. 2013;9:49–54.

    Google Scholar 

  92. Jaddou HY, Bateiha AM, Al-Khateeb MS, Ajlouni KM. Epidemiology and management of hypertension among Bedouins in Northern Jordan. Saudi Med J. 2003;24:472–6.

    PubMed  Google Scholar 

  93. Nuseir Q, Salalmeh AB, Oudat O, Qudah B, Khdarat M. Prevalence and risk factors for hypertension at Princess Haya Bent Al-Hussein Hospital, Jordan. Rawal Med J. 2014;39:365–8.

    Google Scholar 

  94. Jaddou H, Batieha A, Khader Y, Kanaan A, El-Khateeb M, Ajlouni K. Hypertension prevalence, awareness, treatment and control, and associated factors: results from a national survey, Jordan. Int J Hypertens. 2011;2011:828797.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  95. Jaddou H, Bateiha A, Ajlouni K. Prevalence, awareness and management of hypertension in a recently urbanised community, eastern Jordan. J Hum Hypertens. 2000;14:497–501.

    CAS  PubMed  Article  Google Scholar 

  96. Khader Y, Batieha A, Jaddou H, Rawashdeh SI, El-Khateeb M, Hyassat D, et al. Hypertension in Jordan: prevalence, awareness, control, and its associated factors. Int J Hypertens. 2019;2019:3210617.

    PubMed  PubMed Central  Article  Google Scholar 

  97. Kheirallah KA, Liswi M, Alazab R, Bataineh Z, Alzyoud S, Alsulaiman J, et al. Hypertension prevalence, awareness and control levels among Ghawarna: an African-descendant ethnic minority in the Jordan valley. Ethnicity Dis. 2015;25:321.

    Article  Google Scholar 

  98. Shakhatreh FM, Suleiman AA, Mohammed FI, Alwan A-A. Hypertension among females in a highly disadvantaged community in Jordan. Health Care Women int. 2007;29:39–53.

    Article  Google Scholar 

  99. Ezzat EM, Al Amir MA, Ewais AA. Pattern of hypertension in Fayoum governorate. Asian J Med Health. 2019;17:1–8.

    Google Scholar 

  100. Abd Elaziz KM, Dewedar SA, Sabbour S, EL Gafaary MM, Marzouk DM, Aboul Fotouh A. et al. Screening for hypertension among adults: community outreach in Cairo, Egypt. J Public Health. 2015;37:701–6.

    Google Scholar 

  101. El Banna S, Fouad A. Prevalence of pre-hypertension and hypertension in a sample of Egyptian adults and its relation to obesity. Aust J Basic Appl Sci. 2012;6:481–9.

    Google Scholar 

  102. Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999–2000. J Hum Hypertens. 2002;16:305–12.

    CAS  PubMed  Article  Google Scholar 

  103. Najafian J, Nouri F, Mohammadifard N. Association between sleep duration and hypertension: Isfahan Healthy Heart Program, Iran. ARYA Atheroscler. 2019;15:22.

    PubMed  PubMed Central  Google Scholar 

  104. Eghbali M, Khosravi A, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran. Epidemiol Health. 2018;40.

  105. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:1–10.

    Article  Google Scholar 

  106. Amiri ZM, Barzigar A, Kolamroudi HR, Hoseini S, Rezvani S, Shakib RJ. Hypertension in iranian urban population: Prevalence, awareness, control and affecting factors. La Prensa Med Argent. 2015;101:4.

    Article  Google Scholar 

  107. Montazerifar F, Karajibani M, Abbasi M, Bolouri A. Prevalence of obesity and hypertension and related factors among bank employees in Zahedan, 2017. Int J Epidemiol Res. 2019;6:164–70.

    Article  Google Scholar 

  108. Ghaffari S, Pourafkari L, Tajlil A, Sahebihagh MH, Mohammadpoorasl A, Tabrizi JS, et al. The prevalence, awareness and control rate of hypertension among elderly in northwest of Iran. J Cardiovas Thorac Res. 2016;8:176.

    Article  Google Scholar 

  109. Isfeedvajani MS, Zarchi AAK, Heris AM, Sajjadi F, Tavana AM. Evaluation of personnel blood pressure and its risk factors in university affiliated medical centers: Iran’s Health Day 2013. Med J Islamic Repub Iran. 2014;28:36.

    Google Scholar 

  110. Cheraghian B, Asadi-Lari M, Mansournia MA, Majdzadeh R, Mohammad K, Nedjat S, et al. Prevalence and associated factors of self-reported hypertension among Tehran adults in 2011: a population-based study (Urban HEART-2). Med J Islamic Repub Iran. 2014;28:105.

    Google Scholar 

  111. Janghorbani M, Amini M, Gouya MM, Delavari A, Alikhani S, Mahdavi A. Nationwide survey of prevalence and risk factors of prehypertension and hypertension in Iranian adults. J Hypertens. 2008;26:419–26.

    CAS  PubMed  Article  Google Scholar 

  112. Ebrahimi M, Mansournia MA, Haghdoost AA, Abazari A, Alaeddini F, Mirzazadeh A, et al. Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006. J Hypertens 2010;28:1620–9.

    CAS  PubMed  Article  Google Scholar 

  113. Rajati F, Hamzeh B, Pasdar Y, Safari R, Moradinazar M, Shakiba E, et al. Prevalence, awareness, treatment, and control of hypertension and their determinants: results from the first cohort of non-communicable diseases in a Kurdish settlement. Sci Rep. 2019;9:1–10.

    CAS  Article  Google Scholar 

  114. Anwar S, Moslhey GJ, Aleem B, Rashid HH, Alrashdi AS. Predictors of hypertension in Oman. Int J Community Med Public Health. 2019;6:488–94.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

SK, HOA, and AAM were involved in the conception and design of the study. SK, HOA were involved in the investigation and screening of articles and data extraction. SK, HOA, and MM were involved in the analysis and interpretation of data. SK and HOA were involved in the drafting of the manuscript. SK, HOA, and AAM were involved in the critical revision of the manuscript.

Corresponding author

Correspondence to Shiva Kargar.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Okati-Aliabad, H., Ansari-Moghaddam, A., Kargar, S. et al. Prevalence of hypertension and pre-hypertension in the Middle East region: a systematic review & meta-analysis. J Hum Hypertens (2022). https://doi.org/10.1038/s41371-021-00647-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41371-021-00647-9

Search

Quick links